Cluster of differentiation 8 and programmed cell death ligand 1 expression in triple-negative breast cancer combined with autosomal dominant polycystic kidney disease and tuberous sclerosis complex: a case report
ConclusionsProgrammed cell death ligand 1 checkpoint therapy may be effective for recurrence of triple-negative breast cancer in a patient with autosomal dominant polycystic kidney disease and tuberous sclerosis complex.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
More News: Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | Diabetes | Diabetes Mellitus | Dialysis | Disability | Endocrinology | Epilepsy | General Medicine | Genetics | Japan Health | Mastectomy | Neurology | Polycystic Kidney Disease | Renal Failure | Skin | Tuberous Sclerosis | Urology & Nephrology